Most investors would like the world of finance to exist in black or white. Just tell me when to buy or sell, get bullish or bearish, buy this stock or avoid that one, go all in or get out of the market. Markets are hard because most things exist in shades of gray. It’s difficult … Read more
By Michael Kim NASDAQ:LOBO LOBO EV Technologies (NASDAQ:LOBO) designs and manufactures e-Bicycles, e-Mopeds, motorcycles, e-Tricycles, autonomous robotic lawn mowers, and electric off-highway four-wheeled shuttles (golf carts and scooters for elderly and disabled persons) for distribution through a broad-based dealership network in China, Southeast Asia, Latin America, Europe, and the United States. Following the release of … Read more
By Lisa Thompson NYSE:PERF READ THE FULL PERF RESEARCH REPORT On Wednesday, Perfect Corp. (NYSE:PERF) closed its acquisition of Wannaby Inc. Wannaby, known as WANNA on Crunchbase, is the provider of a try-on technology platform for the fashion industry. It is located in Redwood City, California, and Lithuania and has approximately 24 employees. The company … Read more
By Brad Sorensen, CFA NASDAQ:TELO READ THE FULL TELO RESEARCH REPORT Telomir Pharmaceuticals (NASDAQ:TELO) is a preclinical stage biopharmaceutical company developing a product designed to lengthen the DNA’s protective telomere caps. Previously reported preclinical tests have shown evidence that Telomir-1, the company’s primary therapy, can lengthen telomeres and initial animal testing illustrates the potential impact. … Read more
By Thomas Kerr, CFA NASDAQ:CTSO READ THE FULL CTSO RESEARCH REPORT On January 3, 2025, CytoSorbents (NASDAQ:CTSO) reported strong preliminary 4th quarter and full year 2024 financial results which exceeded our expectations. 4th quarter product revenue (excluding grant income) is estimated to be in the range of $9.0-$9.2 million, which is approximately 22% to 25% … Read more